The development of resistance of HIV-1 to zalcitabine

This publication has 52 references indexed in Scilit:

• Genotypic and phenotypic characterization of HIV-1 isolated from patients receiving (−)-2′,3′-dideoxy-3′-thiacytidine
  Antiviral Research, 1995
• Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)
  The Journal of Infectious Diseases, 1995
• Prevalence and Clinical Significance of Zidovudine Resistance Mutations in Human Immunodeficiency Virus Isolated from Patients after Long-Term Zidovudine Treatment
  The Journal of Infectious Diseases, 1995
• Development of HIV-1 resistance to (−)2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complex
  AIDS, 1995
• Zidovudine Resistance and HIV-1 Disease Progression during Antiretroviral Therapy
  Annals of Internal Medicine, 1995
• In vitroanti-HIV and Cytotoxicological Evaluation of the Triple Combination: AZT and ddC with HIV Proteinase Inhibitor Saquinavir (Ro 31-8959)
  Antiviral Chemistry and Chemotherapy, 1994
• Clinical correlates of in vitro HIV-1 resistance to zidovudine. Results of the Multicentre Canadian AZT Trial
  AIDS, 1993
• Synergistic inhibition of replication of human immunodeficiency virus type 1, including that of a zidovudine-resistant isolate, by zidovudine and 2',3'-dideoxycytidine in vitro
  Antimicrobial Agents and Chemotherapy, 1992
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients
  Cell, 1986